ERBB2 and neoplasm: HER2 overexpression is usually caused by gene amplification, and subsequent heterodimerisation with other members of the EGFR family precipitates tumour cell proliferation, invasion and metastasis predominantly through the RAS/MAPK and PI3K/Akt pathways.